Fosun International Limited

Fosun International Limited

0656.HK
Fosun International LimitedHK flagHong Kong Stock Exchange
3.81
HKD
+0.02
- -
30.98BMarket Cap
Fosun International Limited
0656.HK
(Hong Kong Stock Exchange)

Recent

price

3.81

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
6.94
8.83
8.05
7.93
9.18
10.39
8.6
10.27
12.77
16.76
16.12
19.33
22.07
24.25
23.62
21.35
Revenue per Share
0.66
0.53
0.58
0.86
1.02
1.06
1.19
1.54
1.57
1.73
0.94
1.21
-0.1
0.17
-0.53
-2.88
Basic EPS, GAAP
0.23
-1.37
0.43
-0.99
-0.13
-1.03
0.8
2.62
0.2
-0.1
-0.04
-1.47
-1.18
-0.41
1.92
1.9
Free Cash Flow per Basic Share
0.18
0.08
0.03
0.03
0.32
0.07
0.28
0.14
0.12
0.26
0.18
0.11
0.43
- -
0.03
0.03
Dividend per Share
0.1
2.32
2.74
3.44
6.61
9.23
8.98
10.23
11.38
12.27
12.72
13.61
13.45
12.99
12.47
9.54
Book Value per Share
6.79
7.09
8.43
8.77
9.9
10.55
12.44
12.87
14.28
16.1
16.78
17.7
16.62
17.4
16.51
13.08
Tangible Book Value per Share
6,432
6,432
6,432
6,432
6,729
7,582
8,601
8,573
8,560
8,532
8,483
8,345
8,265
8,174
8,135
8,124
Basic Weighted Avg Shares
44,644
56,816
51,765
51,017
61,738
78,797
73,967
88,025
109,352
142,982
136,742
161,291
182,426
198,200
192,142
173,425
Sales/Revenue/Turnover
20.83
10.07
7.55
7.91
5.73
2.05
3.73
6.62
5.65
7.36
5.99
3.82
2.48
1.23
3.54
2.48
Operating Margin (%)
1,857
2,249
1,743
1,741
2,309
3,747
3,177
2,685
3,828
6,698
7,504
7,926
9,007
10,557
10,709
11,540
Depreciation Expense
4,227
3,404
3,707
5,519
6,854
8,038
10,268
13,161
13,406
14,801
8,000
10,085
-832
1,379
-4,349
-23,396
Net Income, GAAP
28.97
26.42
21.25
19.55
24.55
32.31
22.08
26.88
22.66
26.7
34.65
30.7
71.97
32.07
746.9
- -
Effective Tax Rate (%)
9.47
5.99
7.16
10.82
11.1
10.2
13.88
14.95
12.26
10.35
5.85
6.25
-0.46
0.7
-2.26
-13.49
Profit Margin (%)
9,586
14,658
15,762
4,251
12,476
11,512
43,099
16,160
43,285
11,333
17,849
-13,683
-5,864
1,730
-22,173
-15,530
Working Capital
22,046
30,357
30,226
40,223
51,180
68,189
84,804
93,945
122,688
137,913
154,310
131,892
120,640
137,036
124,484
142,003
LT Debt
44,999
48,486
57,218
61,300
75,684
99,553
122,874
136,412
160,441
180,924
193,085
199,609
199,075
208,575
197,539
168,296
Total Equity
8.34
4.27
2.76
2.56
1.7
0.55
0.9
1.54
1.46
1.98
1.23
0.94
0.28
0.37
-9.67
- -
Return on Invested Capital (%)
14.35
4.75
5.06
5.01
4.85
4.3
5.05
5.17
4.9
4.57
2.74
2.28
-0.41
1.33
-20.91
- -
Return on Capital (%)
680.15
43.83
22.79
27.75
20.58
14.05
13.95
15.97
14.49
14.65
7.53
9.11
-0.74
1.27
-4.19
-26.15
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.93%
-2.44%
-14.8%
Free Cash Flow
308.85%
670.9%
-1.22%
Net Income, GAAP
-30.31%
-65.07%
437.97%
Sales/Revenue/Turnover
9.04%
5.38%
-9.74%
Total Cash Common Dividend
112.19%
144.08%
-19.29%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
198,200
2024
- -
- -
- -
- -
192,142
2025
- -
- -
- -
- -
173,425

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.17
2024
- -
- -
- -
- -
-0.53
2025
- -
- -
- -
- -
-2.88

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
0.03
2025
- -
- -
- -
- -
0.03
Business
Fosun International Limited is a diversified investment conglomerate headquartered in Shanghai, China, founded in 1992. The company operates across multiple sectors including health, happiness, wealth, and intelligent manufacturing, with an extensive global footprint spanning over 35 countries. Fosun's core products and services encompass healthcare products and pharmaceuticals under Fosun Pharma; tourism and leisure services including the global vacation brand Club Med and new offerings such as Super Resort, Super Resort Complex, and Super Culture and Tourism Mall; financial services with a focus on insurance and investment; and real estate development and management. In healthcare, Fosun Pharma leads with a broad portfolio of pharmaceuticals, biologics, medical devices, and health management solutions, supported by substantial R&D investments and innovation in drug development. The tourism segment focuses on transforming China's tourism from sightseeing to vacationing, leveraging premium service brands like Club Med to offer diversified cultural and experiential products. Financial services include insurance and asset management, with recent strategic portfolio shifts such as the sale of the Ageas stake, reflecting a recalibration of its insurance business. The real estate division develops integrated urban complexes and operates in key domestic and international markets. Recent major developments include a strategic cooperation agreement signed in January 2025 with Natixis Corporate & Investment Banking to deepen collaboration in advisory, financing, transaction structuring, and risk hedging to support Fosun's global development. In late 2025, Fosun Tourism Group launched three core product lines—Super Resort, Super Resort Complex, and Super Culture and Tourism Mall—aimed at responding to evolving domestic tourism demands and enhancing vacation experience offerings. The company also reinforced its commitment to innovation and globalization, with 2024 and 2025 seeing increased investment in healthcare R&D and international expansion efforts. These strategic moves underscore Fosun's focus on expanding its ecosystem and driving sustainable growth across its diversified portfolio. Fosun International targets high-value consumer segments and institutional clients, leveraging its integrated ecosystem approach known as customer-to-maker (C2M), to connect industries and brands. Its operations span Mainland China, Europe, the Americas, and emerging markets, with subsidiaries and affiliates exceeding 300 entities worldwide. Fosun maintains a strong commitment to sustainability and ESG principles, recognized in the S&P Global Sustainability Yearbook 2025 and continually featuring in major ESG indexes. Overall, Fosun International Limited remains a major investment group with diversified business units focused on delivering quality products and services across healthcare, tourism, financial services, and intelligent manufacturing, supported by recent strategic partnerships and a clear emphasis on innovation and globalization to sustain long-term growth.